Latest Stock Research & Market Analysis
Stock Research
Cochlear (ASX: COH) – Oversold In Turmoil
Cochlear (ASX: COH) is one of the world’s leading heath technology firms with global dominance in the internal and external hearing aid space. The stock has reacted sharply to tariff concerns and its impact on the company along with cost overruns and disappointing...
Telstra Group (ASX: TLS): Dominance Pays
Telstra (ASX: TLS) stands as Australia's premier telecommunications provider with an exceptional telecom asset foundation and leading market position across mobile and internet services. Beyond being a top customer-oriented service provider, Telstra's infrastructure...
Webjet Group (ASX: WJL): A Re-Energised B2C Travel Leader Post-Demerger
Webjet Group Limited (ASX: WJL) is a leading digital consumer travel business comprising two key businesses and a technology company. The company recently completed a demerger from WEB Travel Group (formerly Webjet Limited) on September 30, 2024, positioning itself as...
Pro Medicus (ASX: PME) – A Secular SaaS Growth Story
Pro Medicus (ASX: PME) is a health tech software company providing imaging tools and services to clients such as hospitals, diagnostic chains, and independent practices. The company's growth was significantly boosted by the logistical disruptions of the COVID-19...
Amcor (ASX: AMC) – Poised To Re-rate On Better Macro Conditions
Amcor (ASX: AMC) has had a rough couple of years owing to high rates and inflation, which crippled customer spending and changed spending patterns. Given the high volume and commoditized nature of Amcor’s business, revenues and earnings...
Subscribe
Want more Free Research?
Subscribe today for free and get an alert when we have new research and webinars.
Top Stock Reports
5 Best Shares to Buy Right Now in Australia
Finding the best shares to buy right now can be challenging, especially in a volatile market. For Australian investors, identifying opportunities on the ASX (Australian Securities Exchange) requires careful consideration of both short-term performance and long-term...
![5 Best Dividend Stocks to Buy [ASX Blue Chip Stocks]](https://mfam.com.au/wp-content/uploads/2021/08/dividend-stocks-to-buy-2-400x250.png)
5 Best Dividend Stocks to Buy [ASX Blue Chip Stocks]
When it comes to dividend investing, finding the best dividend stocks on the ASX can provide both reliable income and long-term portfolio resilience. The ASX offers a diverse range of high dividend stocks, including market leaders with stable revenues and a track...
![5 Best Lithium Stocks ASX 2023 [Australian Lithium Stocks]](https://mfam.com.au/wp-content/uploads/2021/09/best-lithium-stocks-to-buy-400x250.webp)
5 Best Lithium Stocks ASX 2023 [Australian Lithium Stocks]
Today, we will look at some of the best lithium stocks on the ASX 200 to buy for 2023. These Australian lithium stocks have great leverage to one of the fastest growing sectors in Australia. Lithium is a massively growing industry with the advent of clean energy and...
Opinions & Guides
Here is How a Repeatable Pattern Gave Investors 24% Gain in Wesfarmers Stock in 6 Months
Part of stock analysis involves undertaking fundamental analysis, technical analysis or a combination of both. Although, it would be nice if everything was as simple as black and white without any inconsistency. For instance, mathematical measures of intrinsic value...
Is the RBA done with rate hikes?
They say, “hope for the best, and be prepared for the worst”. This is the message that Lowe appeared to be sending last week to mortgage holders, telling the world that interest rates “may well” rise again. Given the balance of risks and the outrage resulting from...
Why the RBA Should Press Pause on Rate Hikes… Soon
The Reserve Bank (RBA) has been in a tough spot lately. Yes, it misread the economy in the aftermath of the pandemic. But the RBA wasn’t the only central bank that went all out in providing stimulus. It wasn’t just the RBA that was late in recognising inflation risks....
MF & Co. Asset Management
MF & Co. Asset Management is a boutique investment firm offering Equity Capital Markets and derivative general advice & trade execution services.
We are specialists in advising and trading in Australian and US Equities, Index & Equity Options and Options on Futures.
Contact
Get In Touch
Australia
1300 889 603
International
+61 2 8378 7199
M-F: 8am-5pm
Suite 803, Level 8
70 Pitt St, Sydney, NSW 2000